A 64-year-old woman was referred to our center presenting with thirst, malaise, and pain in both legs which occurred one week before admission. She was revealed to have hyperglycemia and diabetic ketoacidosis (DKA). After therapy for diabetic ketoacidosis was started, her blood glucose levels were improved, but urinary ketone body excretion persisted. Laboratory examination indicated a significant impairment of insulin secretion, although anti-GAD and anti-IA-2 antibody were not detected. After admission, she complained about weakness of lower extremities, which spread to her upper extremities. The diagnosis of Guillain-Barré syndrome (GBS) was made based on the nerve conduction study and cerebrospinal fluid analysis. The intravenous immunoglobulin therapy was started, and her muscle weakness showed gradual improvement. Although the possibility that GBS was casually accompanied with DKA could not be completely excluded, we considered that DKA triggered the development of GBS in this case. Although GBS is a rare condition, the present case suggests that GBS should be included in the differential diagnosis of DKA with its atypical course.
Introduction
Diabetic ketoacidosis (DKA) is a serious acute complication of diabetes mellitus, which is a life-threatening disease characterized by hyperglycemia and increased ketone bodies. DKA is caused by insulin insufficiency which leads to decreased glucose utilization, and increased gluconeogenesis and ketone body production through elevated counter regulatory hormones, including catecholamines, glucagon, and cortisol (1) . Guillain-Barré syndrome (GBS) is an acute immune-mediated peripheral neuropathy. The clinical features of GBS are characterized by progressive limb weakness, and absent or depressed deep tendon reflexes. GBS sometimes results in fatal outcome, due to respiratory failure and autonomic dysfunction (2) . Here, we report a case of DKA who developed GBS during the treatment of DKA.
Case Report
A 64-year-old woman was referred to our hospital because of thirst, malaise, and pain in both legs. She had no past medical history including diabetes mellitus, but her brother had diabetes. She had no recent episode of diarrhea or upper respiratory symptom. One week before the admission, she developed thirst, general malaise, and pain in both legs. She was admitted to a nearby hospital, where she was pointed out to have hyperglycemia and positive urinary ketone body. Intravenous infusion of physiological saline and insulin was given and subcutaneous insulin infusion was subsequently started. However, her symptoms did not show any improvement and hyperglycemia and positive urinary ketone body persisted. She was transferred to our hospital for further examination and treatment.
On admission, her height was 158 cm and weight was 63 kg. She was alert but lethargic. Her blood pressure was 177/ 111 mmHg and pulse rate was 96/min. Impairment of perception and sense of vibration was present in both legs, while the deep tendon reflexes were preserved. The physical examination was otherwise normal, except for the funduscopic examination which showed simple diabetic retinopathy. As shown in Table 1 , the routine laboratory examinations revealed high blood glucose and HbA1c level, volume depletion, hyponatremia, and metabolic acidosis with increased anion gap, but acidemia was not present. Both urine and serum showed an increased ketone body. Based on these findings, she was diagnosed as DKA, and treatment was started. Glucagon-stimulated insulin response test revealed impaired insulin secretion. Anti-GAD antibody and anti-IA-2 antibody were negative. Urinary albumin excretion indicated the presence of early diabetic nephropathy. Plasma ACTH, cortisol and urinary free cortisol excretion were high, and the diurnal variation of ACTH and cortisol was lost, suggesting a possibility of Cushing disease. However, it was excluded since the low-dose (0.5 mg) dexamethasone suppression test showed a normal cortisol response (Table 2 ). These results suggested that the abnormal cortisol secretion was attributable to stress. Plasma ACTH and cortisol were gradually decreased thereafter (Fig. 1) .
After intravenous supply of fluid and insulin after admission, intensive subcutaneous insulin injection therapy was initiated. Her blood glucose levels were rapidly improved and hyponatremia, which was thought to be pseudohypona- tremia due to hyperglycemia, was also corrected. But urinary ketone excretion persisted until the eighth hospital day (Fig. 1) . On the fourth day, she suddenly developed lower extremities weakness. The weakness gradually progressed and she became unable to stand up. On the following day, muscle weakness spread to upper extremities. Plasma potassium concentration was within normal range (4.0 mEq/L). Although her mental status remained normal, and the cranial nerves were intact, she showed muscle symmetrical weakness, which was dominant in her proximal limb muscle. The tendon reflex was depressed and the glove-and-stocking type of paresthesia was present. Nerve conduction study was performed, which showed slow conduction velocity, prolonged distal latency, delayed F wave, and small compound muscle action potential (Table 3) . Cerebrospinal fluid analysis revealed elevated protein level (410.2 mg/dL) with a normal cell count (4/μL). Based on these clinical and laboratory findings, although the patient did not have any antibodies against gangliosides (Table 4) , she was diagnosed as GBS. Intravenous immunoglobulin (0.4 g/kg/day) was administered for consecutive five days and her muscle weakness showed a gradual improvement (Fig. 1) . On the 15 th day, the nerve conduction study was performed again, but did not show significant improvement of conduction velocity and compound muscle action potential ( Table 3 ), suggesting that she had already had advanced diabetic neuropathy.
She was discharged on the 29 th day, walking on her own.
She continued rehabilitation and insulin therapy.
Discussion
Here we reported a woman with DKA followed by the development of GBS. The diagnosis of GBS was made based on the nerve conduction study and cerebrospinal fluid analysis. Since GBS has the potential to cause ventilatory failure requiring mechanical ventilation and the treatment is more effective if given early after the onset (3), it is mandatory to obtain cerebrospinal fluid and perform nerve conduction study when GBS is suspected.
GBS is triggered by infection in three quarters of the patients. There are only three case reports of the association of DKA and GBS, to our knowledge, in the literature (4-6). Among the previously reported four patients, three had antecedent infections (diarrhea, bronchial infection, and sepsis), one did not have such an infection. The present patient had no history of symptoms which suggested some infection before developing GBS.
We diagnosed our patient as DKA in spite of the absence of acidosis, because acidosis was thought to be modified by insulin therapy which had already been started at nearby hospital. According to the high level of HbA1c, it is suggested that she had had poorly controlled diabetes for a certain period. Although her endogenous insulin secretion was decreased, islet-related autoantibody was not detected. Therefore, we diagnosed that her diabetes was type 2. Al- though DKA typically occurs in type 1 diabetes, it is also known to be occur in type 2 diabetes (7, 8) , under conditions such as serious infection, trauma, cardiovascular emergency, and omission of treatment (1) . The present patient did not have such an event. In a report, however, about half of type 2 diabetes patients who developed DKA had no identifiable antecedent or concurrent stressful condition (8) .
Abnormal secretion and loss of diurnal variation of cortisol was thought to be caused not by Cushing's syndrome but by stress. Although she had no apparent stressful event, some stress led to abnormal cortisol secretion, which might have resulted in the development of DKA. In addition, it is conceivable that this excessive cortisol caused sustained ketonuria through the increased stimulation of lipolysis (9) .
The pain in legs was thought to be due to painful diabetic neuropathy or GBS. The most common pains observed in GBS are deep aching back, leg pain, and dysesthetic extremity pain. These pains are early symptoms of GBS and usually resolve over the first eight weeks (10) . On the other hand, pain in diabetic neuropathy begins in the lower limbs, typically affecting the toes first, and then progressing upward. Severe diabetic neuropathy, long duration of diabetes Table 4 . Antibodies against Gangliosides
and poor glycemic control are associated with increasing risk of painful diabetic neuropathy (11) . Pain of painful diabetic neuropathy is usually self-limiting. Remission is more likely if the onset of symptoms has followed a sudden metabolic change, such as DKA or improvement of glycemic control (12) . In the present case, the pain resolved after about 10 th hospital day without any treatment for the pain. This clinical course was consistent with both GBS and painful diabetic neuropathy, thus it was difficult to confirm the cause of the pain.
Rouanet-Larriviere et al reported a concept that both type 1 diabetes and GBS might share an autoimmune mechanism which might be triggered by a common event, viral infection in particular (6). This discussion was based on one previous epidemic study (13) . This study reported that the incidence of both GBS and type 1 diabetes showed an increase following the fluctuations in numbers of small rodents, suggesting that some novel viral infection was involved. However, no autoantibodies associated with both diabetes and GBS were found and no history of infections was observed in the present case. Therefore, in this case, an autoimmune mechanism was unlikely to be involved in the pathogenesis. Rare cases of GBS occur in the presence of underlying systemic disease, such as systemic lupus erythematosus, Hodgkin's lymphoma, general surgery, and other medical illness (14, 15) . Therefore, although it was difficult to exclude the possibility that the association of DKA and GBS was a casual result, it was conceivable that DKA might have been the cause of GBS in the present case.
Although the association of DKA and GBS is very rare, and DKA is atypical as the preceding event of GBS, the present case suggests that GBS should be included in the differential diagnosis of DKA with its atypical course, since GBS may be life-threatening. In summary, we reported a rare case of DKA associated with GBS. It is important to suspect GBS as the cause of acute developing muscle weakness in cases of prolonged DKA, especially that associated with muscle weakness.
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